Pathios Therapeutics
Milton, United Kingdom · Founded 2017 · $33.8M raised
- Headquarters
- Milton
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- pathiostherapeutics.com
- Total Funding
- $33.8M
- Last Round
- $25.0M Series BApr 2024
- Rounds
- 3
About
Pathios Therapeutics is a clinical-stage oncology and immunology company targeting GPR65 to restore immune response to cancer.
Summary
Pathios Therapeutics is a Biotech company based in Milton, United Kingdom, founded in 2017. It has raised $33.8M in total across 3 rounds, most recently a $25.0M Series B round in Apr 2024. Investors include Brandon Capital Partners, Canaan Partners and Innovate UK.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...